Activation and discovery of tsukubarubicin from Streptomyces tsukubaensis through overexpressing SARPs

Genome sequencing has revealed that each Streptomyces contains a wide range of biosynthetic gene clusters (BGCs) and has the capability to produce more novel natural products than what is expected. However, most gene clusters for secondary metabolite biosynthesis are cryptic under normal growth conditions. In Streptomyces tsukubaensis , combining overexpression of the putative SARPs ( Streptomyces antibiotic regulatory proteins) and bioactivity-guided screening, the silent gene cluster ( tsu ) was successfully activated and a novel bioactive anthracycline tsukubarubicin was further isolated and identified. Biological activity assays demonstrated that tsukubarubicin possessed much better antitumor bioactivities against various human cancer cell lines (especially the breast cancer cell lines) than clinically used doxorubicin. Moreover, the previously unreported gene cluster ( tsu ) for biosynthesis of tsukubarubicin was first characterized and detailed annotations of this gene cluster were also conducted. Our strategy presented in this work is broadly applicable in other Streptomyces and will assist in enriching the natural products for potential drug leads. Key points • Generally scalable strategy to activate silent gene clusters by manipulating SARPs . • The novel anthracycline tsukubarubicin with potent antitumor bioactivities . • Identification and annotation of the previously uncharacterized tsu gene cluster .